Business · 30/01/2007
Indevus Pharmaceuticals, Inc. Seeks Withdrawal of FDA Approval for REDUX Capsules
The FDA is withdrawing approval of a new drug application for REDUX capsules, a product no longer marketed by Indevus Pharmaceuticals, Inc., due to a request from the company.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →